Published in Oncogene on September 09, 2002
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell (2008) 3.32
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res (2006) 3.29
BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol (2004) 2.46
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev (2007) 1.75
Transcriptional program of ciliated epithelial cells reveals new cilium and centrosome components and links to human disease. PLoS One (2012) 1.32
The CRM1 nuclear export protein in normal development and disease. Int J Biochem Mol Biol (2012) 1.14
New players in the BRCA1-mediated DNA damage responsive pathway. Mol Cells (2008) 1.13
Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol Biol Cell (2004) 1.09
PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Int J Med Sci (2006) 1.07
Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1. Mol Cell Biol (2004) 1.03
Global approaches to understanding ubiquitination. Genome Biol (2005) 1.03
The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. BMC Cancer (2007) 1.00
TopBP1 localises to centrosomes in mitosis and to chromosome cores in meiosis. Chromosoma (2004) 0.98
Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform. Mol Cell Biol (2006) 0.93
Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1. Exp Cell Res (2007) 0.92
Centrosomal Nlp is an oncogenic protein that is gene-amplified in human tumors and causes spontaneous tumorigenesis in transgenic mice. J Clin Invest (2010) 0.88
Spontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells. Proc Natl Acad Sci U S A (2013) 0.85
Identification and functional characterization of a PP1-binding site in BRCA1. Biochem Biophys Res Commun (2007) 0.85
BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression. J Biol Chem (2009) 0.85
Is homologous recombination really an error-free process? Front Genet (2014) 0.85
Association of loss of BRCA1 expression with centrosome aberration in human breast cancer. J Cancer Res Clin Oncol (2008) 0.84
HTLV-1 Tax: centrosome amplification and cancer. Retrovirology (2006) 0.81
The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis. Br J Cancer (2011) 0.79
Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines. Cancer Biol Ther (2010) 0.79
Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities. Cell Cycle (2016) 0.75
Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression. Cell Cycle (2017) 0.75